By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Cepheid yesterday filed a countersuit against Abaxis claiming that it is not infringing any Abaxis patents and that, among other claims, Abaxis filed its suit "without reasonable basis and in bad faith."
...and receive Daily News bulletins.
Already have an account?Login Now.
This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.
In this webinar, Kevin Balbi, head of bioinformatics at Sarah Cannon Molecular Diagnostics, will discuss the validation of targeted sequencing panels on the Ion Torrent platform using Horizon Discovery’s Tru-Q controls.